The provider of a range of services to the healthcare sector in the UK.
30-Nov-2017 – 32.5p – £19.4m – PER n/a
Trading Update – In-line with Cash expected to be significantly ahead of expectations, £8m versus £4.1m.
A new one to me and I am not sure what to make of this. It’s clearly got lots of Cash but I have no idea what the real forecasts are. I will keep an eye out for a more detailed update in the future.
6-Nov-2019 – 29p – £72m – PER 4
Interim Results For The 6 Months To End September 2019 – Revenue up 20% or so, EBITDA up 30% or so, intends to pay a maiden Dividend, Cash at Bank £8.4m (£7.5m). This is in-line and pipeline remains strong.
Looks more interesting, will be looking for Broker notes this morning, concern on the margin.